Bank of Montreal’s Gilead Sciences GILD Stock Holding History

Bank of Montreal’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,400	Closed	-$941K	–	3599
2025 Q1	$941K	Buy	+8,400	New	+$867K	﹤0.01%	1853
2022 Q2	–	Sell	-15,000	Closed	-$1.27M	–	4208
2022 Q1	$1.27M	Buy	+15,000	New	+$959K	﹤0.01%	2185
2019 Q1	–	Sell	-19,200	Closed	-$1.2M	–	4481
2018 Q4	$1.2M	Buy	+19,200	New	+$1.34M	﹤0.01%	1797
2018 Q3	–	Sell	-79,100	Closed	-$5.6M	–	4790
2018 Q2	$5.6M	Buy	+79,100	New	+$5.59M	﹤0.01%	1115
2017 Q4	–	Sell	-27	Closed	-$2K	–	4220
2017 Q3	$2K	Sell	27 -46	-63%	-$3.52K	﹤0.01%	4030
2017 Q2	$5K	Buy	+73	New	+$4.86K	﹤0.01%	3869
2016 Q4	–	Sell	-27	Closed	-$2K	–	4104
2016 Q3	$2K	Buy	+27	New	+$2.19K	﹤0.01%	3848
2015 Q1	–	Sell	-105,500	Closed	-$9.94M	–	4057
2014 Q4	$9.94M	Buy	+105,500	New	+$10.9M	0.01%	781

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal's GILD Position: Q2 2026 in Review

Bank of Montreal increased its Gilead Sciences (GILD) stake by 6.3% in Q2 2026, buying an estimated $29.4M and bringing the position to 3,772,428 shares worth $477M. The position accounts for 0.16% of the portfolio, ranked #117.

Bank of Montreal first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $576M in Q2 2015. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Bank of Montreal held 3,772,428 shares of Gilead Sciences worth $477M as of Q2 2026.
Bank of Montreal bought 223,204 Gilead Sciences shares in Q2 2026, an estimated $29.4M.
Gilead Sciences made up 0.16% of Bank of Montreal's portfolio in Q2 2026, its #117 holding.
Bank of Montreal first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Bank of Montreal's Gilead Sciences position peaked at $576M in Q2 2015.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.